Ministry of Health allows distribution of 30,000 Remdesivir vials
The Ministry of Health on August 21 allowed the distribution of 30,000 more vials of the antiviral drug Remdesivir to treat COVID-19 patients in a number of localities.
Hanoi (VNA) – The Ministry of Health on August 21allowed the distribution of 30,000 more vials of the antiviral drug Remdesivir totreat COVID-19 patients in a number of localities.
Recipients include 11 hospitals, 12 departments ofhealth in cities and provinces consisting of HCM City, Binh Duong, Dong Nai,Tra Vinh, Vinh Long, Da Nang, Phu Yen, Khanh Hoa, Soc Trang, Ben Tre, KienGiang and Hau Giang, and the health division of the Military Medicine Department.
Earlier, 10,000 vials were distributed on August 8 for Ho Chi Minh City and a number of southern provinces. Another 30,000vials of the drug were recently distributed on August 17 for 17 hospitals andhealth departments in the south.
Remdesivir was the first antiviral drug approved by the USFood and Drug Administration (FDA) in October, 2020 for treating COVID-19 patients. Ithas the ability to shorten treatment times and speed up recovery for criticallyill patients.
The drug has been approved and authorised for use inapproximately 50 countries worldwide. It is now one of the world's leadingspecialised drugs.
On August 2, with the ministry’s guidance, conglomerate Vingrouphad successfully negotiated for 500,000 vials of Remdesivir from Indianpharmaceutical company Cipla under licensing agreement from US-based GileadSciences. The first batch arrived at Tan Son Nhat International Airport in HCMCity on August 5./.
Deputy Health Minister Nguyen Truong Son signed a decision issuing diagnosis and treatment guidelines for the acute respiratory disease caused by the novel coronavirus SARS-CoV-2 (COVID-19), the Health Ministry reported on March 26.
The Vietnam Academy of Science and Technology on June 28 announced that its Institute of Chemistry has successfully found out a new method for synthesising anti-SARS-CoV-2 drug from Favipiravir in the laboratory.
Approximately 10,000 vials of Remdesivir, a broad-spectrum antiviral drug licensed by the US Food and Drug Administration for COVID-19 treatment arrived in Vietnam on August 5 evening.
Around 10,000 vials of Remdesivir have been distributed to 10 hospitals in Ho Chi Minh City to treat COVID-19 patients starting today, according to the Ministry of Health
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Treating a COVID-19 patient (Source: VNA) 
